Dr. Seyed Mohammad Kazem Aghamir is a distinguished urologist and researcher who currently serves as the Head of the Urology Research Center at Tehran University of Medical Sciences. With decades of experience in both clinical practice and research, Dr. Aghamir has made significant contributions to the field of endourology, minimally invasive surgery, and kidney transplantation. His work has been instrumental in advancing urological care and improving outcomes for patients with complex conditions such as kidney stones and urological cancers. He is also the Vicegerent of Sina Hospital and a Director of Endourology at Tehran University of Medical Sciences. Dr. Aghamir’s leadership roles, combined with his prolific research output and innovative patents, have earned him recognition as one of the foremost figures in his field.
Profile
ORCID
Education
Dr. Aghamir’s educational background is as diverse as it is impressive. He earned his MD from Shahid Beheshti University of Medical Sciences, Tehran, in 1994. This was followed by a specialization in urology at Tehran University of Medical Sciences, where he completed his residency between 1996 and 2000. His pursuit of expertise led him to obtain a fellowship in Endourology from Shahid Beheshti University of Medical Sciences in 1999-2000. Dr. Aghamir also completed a short fellowship in Retrograde Intra-renal Surgery (RIRS) at Tenon Hospital in France in 2013, further solidifying his expertise in minimally invasive urological surgery.
Experience
With over two decades of experience in urology, Dr. Aghamir has held several key positions. He is the Head of the Urology Research Center at Tehran University of Medical Sciences and serves as the Director of the Endourology group at the same institution. His leadership extends to his role as Vicegerent of Sina Hospital, where he oversees clinical and administrative operations. Dr. Aghamir is also a respected mentor to many young urologists and researchers in Iran, helping to shape the future of urological care. His clinical focus is primarily on advanced minimally invasive urological procedures and the management of complex kidney conditions.
Research Interest
Dr. Aghamir’s research interests lie in the areas of endourology, kidney transplantation, and urological oncology. He is particularly interested in the application of genomics and molecular biology in improving outcomes for patients undergoing kidney transplantation. His work in whole exome sequencing for kidney transplantation efficacy and his studies on the effects of COVID-19 on genitourinary cancers reflect his dedication to translational research that bridges clinical practice and molecular science. He is also deeply involved in research focused on improving techniques for minimally invasive surgery, such as shockwave lithotripsy and retrograde intra-renal surgery.
Award
Dr. Aghamir has been the recipient of numerous awards throughout his career. His groundbreaking research in the field of endourology and kidney transplantation has earned him national and international recognition. He has also been honored for his contributions to clinical innovation through his patents for medical devices such as the Methyloscope and anastomosis aids. His leadership at the Urology Research Center and Sina Hospital has been widely acknowledged, solidifying his reputation as a leader in both academic and clinical medicine.
Publications
Dr. Aghamir has authored numerous peer-reviewed articles in leading scientific journals. Below are some of his key publications:
- Whole Exome Sequencing to Find Candidate Variants for the Prediction of Kidney Transplantation Efficacy (2023), Genes. Link to article
Cited by: 5 articles
- The Impact of Conventional Smoking Versus Electronic Cigarette on VEGF, PEMPA1, and PTEN in Rat Prostate (2023), Prostate International. Link to article
Cited by: 3 articles
- Does the Prone Position During Shockwave Lithotripsy Improve the Stone-Free Rate? (2023), Urology Journal. Link to article
Cited by: 7 articles
- Salivary and Serum Periostin in Kidney Transplant Recipients (2023), PLOS ONE. Link to article
Cited by: 4 articles
- 15-Year National Trends of Genital Cancer Incidence Among Iranian Men and Women (2005–2020) (2023), BMC Public Health. Link to article
Cited by: 10 articles
Conclusion
Given Dr. Aghamir’s extensive contributions to urological research, leadership in both clinical and academic settings, and commitment to innovation through patents and publications, he is a highly deserving candidate for the “Best Researcher Award.” His work in genetic prediction models, novel treatments, and translational research has had a significant impact on improving patient care. With some focused efforts to consolidate his research areas and extend his mentorship, Dr. Aghamir could further enhance his already impressive career trajectory.